Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 21, 2022--
The "Cancer Stem Cell Market By Cancer Type, By Transplant, By End-use, and By Region Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
The Global Cancer Stem Cells Market size is estimated to reach USD 2.98 Billion from USD 1.14 Billion in 2021, delivering a growth rate of 11% through 2030, according to a new report.
Companies Mentioned
The increasing investment in research and development of CSC-based therapies is a major factor driving the growth of the Cancer Stem Cell market.
Cancer stem cells (CSCs) are a type of cancer cell that has the ability to divide and renew itself, as well as produce all the other types of cells found in the tumor. CSCs are thought to be responsible for tumor growth, metastasis, and recurrence.
The rising incidence of cancer globally is the major factor driving the growth of the Cancer Stem Cell market. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, with an estimated 9.6 million deaths in 2018. The WHO estimates that the number of cancer cases will rise to about 24 million by 2035.
The high cost of CSC-based therapies is a major factor restraining the growth of the Cancer Stem Cell market. CSC-based therapies are still in the early stages of development and are not yet commercially available. As such, they are typically very expensive and not covered by insurance.
The treatment of cancer can damage the hematopoietic stem cells that are responsible for the production of blood cells, which can lead to a decrease in the number of red blood cells, white blood cells, and platelets. This condition is known as myelosuppression. Myelosuppression can be a side effect of chemotherapy and radiation therapy.
Embryonic stem cells are the main source of stem cells for therapeutic purposes due to their ability to indefinitely divide and differentiate into any cell type in the body. However, embryonic stem cells are difficult to obtain and culture, which has limited their use in clinical applications. Cancer stem cells (CSCs), a subpopulation of cancer cells that possess characteristics of normal stem cells, have been shown to be more resistant to chemotherapy and radiation therapy than other cancer cells.
Further key findings from the report suggest:
For the purpose of this report, the author has segmented the Global Cancer Stem Cells Market on the basis of treatment type, disease type, end-user, and region:
Cancer Type Outlook (Revenue, USD Billion; 2019-2030)
Transplantation Outlook (Revenue, USD Billion; 2019-2030)
End-use Outlook (Revenue, USD Billion; 2019-2030)
Regional Outlook (Revenue, USD Billion; 2019-2030)
For more information about this report visit https://www.researchandmarkets.com/r/177b01
View source version on businesswire.com:https://www.businesswire.com/news/home/20220921005855/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/21/2022 12:36 PM/DISC: 09/21/2022 12:36 PM
http://www.businesswire.com/news/home/20220921005855/en